Tonix Pharmaceuticals Holding Corp.

DB:TPM0 Stock Report

Market Cap: €11.8m

Tonix Pharmaceuticals Holding Future Growth

Future criteria checks 2/6

Tonix Pharmaceuticals Holding is forecast to grow earnings and revenue by 11.5% and 75.6% per annum respectively while EPS is expected to grow by 62.7% per annum.

Key information

11.5%

Earnings growth rate

62.7%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate75.6%
Future return on equityn/a
Analyst coverage

Low

Last updated01 Aug 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:TPM0 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202522-93N/AN/A2
12/31/202414-89N/AN/A3
12/31/20236-110N/AN/A3
3/31/2023N/A-123-132-100N/A
12/31/2022N/A-117-146-98N/A
9/30/2022N/A-112-167-98N/A
6/30/2022N/A-102-156-88N/A
3/31/2022N/A-98-141-86N/A
12/31/2021N/A-92-111-76N/A
9/30/2021N/A-80-81-67N/A
6/30/2021N/A-73-80-69N/A
3/31/2021N/A-64-69-60N/A
12/31/2020N/A-52-57-49N/A
9/30/2020N/A-46-45-41N/A
6/30/2020N/A-42-33-33N/A
3/31/2020N/A-34-27-27N/A
12/31/2019N/A-31-27-27N/A
9/30/2019N/A-31-27-27N/A
6/30/2019N/A-28-25-25N/A
3/31/2019N/A-29-26-26N/A
12/31/2018N/A-29-24-24N/A
9/30/2018N/A-24-22-22N/A
6/30/2018N/A-24-22-22N/A
3/31/2018N/A-23-21-21N/A
12/31/2017N/A-21-19-19N/A
9/30/2017N/A-23-20-20N/A
6/30/2017N/A-25-23-23N/A
3/31/2017N/A-30-27-27N/A
12/31/2016N/A-39N/A-37N/A
9/30/2016N/A-45N/A-44N/A
6/30/2016N/A-50N/A-48N/A
3/31/2016N/A-52N/A-49N/A
12/31/2015N/A-48N/A-43N/A
9/30/2015N/A-44N/A-39N/A
6/30/2015N/A-38N/A-31N/A
3/31/2015N/A-32N/A-28N/A
12/31/2014N/A-28N/A-23N/A
9/30/2014N/A-22N/A-18N/A
6/30/2014N/A-18N/A-16N/A
3/31/2014N/A-14N/A-11N/A
12/31/2013N/A-11N/A-9N/A
9/30/2013N/A-10N/A-6N/A
6/30/2013N/A-8N/A-5N/A
3/31/2013N/A-9N/A-5N/A
12/31/2012N/A-9N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TPM0 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TPM0 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TPM0 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TPM0's revenue (75.6% per year) is forecast to grow faster than the German market (4.6% per year).

High Growth Revenue: TPM0's revenue (75.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TPM0's Return on Equity is forecast to be high in 3 years time


Discover growth companies